Retension Pharmaceuticals

Retension Pharmaceuticals, a biotech company based in Falls Church, Virginia, is planning an initial public offering. Proceeds would be used to advance the company's hypertension drug candidate through development. The move would give the small drug developer access to public markets to fund late-stage testing of its treatment for high blood pressure, a condition affecting a large share of adults.